Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 14, 2026 07:00 ET | Source: Tiziana Life Sciences Ltd.

Tiziana Reports Reduced Brain Inflammation in Multiple System Atrophy Patients Treated with Intranasal Foralumab

BOSTON, May 14, 2026 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana”), a biotechnology company developing its lead candidate, intranasal foralumab, a fully human, anti-CD3...
December 03, 2025 10:28 ET | Source: Research and Markets

United States PET Scanners Market Report 2025-2033: Advances in Hybrid Imaging Technologies Like PET/CT and PET/MRI Bolster Growth

Dublin, Dec. 03, 2025 (GLOBE NEWSWIRE) -- The "United States PET Scanners Market Report by Products Product Type, Modality, Application, End Use, States and Company Analysis, 2025-2033" report has...
May 09, 2025 07:00 ET | Source: Tiziana Life Sciences Ltd.

Tiziana Life Sciences Announces Significant Reduction in Microglia Activation in PET Scan of Moderate Alzheimer's Patient Treated with Intranasal Foralumab

NEW YORK, May 09, 2025 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with...
February 13, 2025 07:33 ET | Source: Research and Markets

Positron Emission Tomography (PET) Scanners Global Market Overview 2024-2030: PET Imaging Gains Traction with New Radiotracers and Enhanced Treatment Monitoring

Dublin, Feb. 13, 2025 (GLOBE NEWSWIRE) -- The "Positron Emission Tomography (PET) Scanners - A Global Market Overview" report has been added to ResearchAndMarkets.com's offering. The global...
February 05, 2025 09:30 ET | Source: SNS Insider pvt ltd

Nuclear Medicine Market Size to Accumulate Around USD 38.8 Billion by 2032, Growing at a 15% CAGR - SNS Insider

Pune, Feb. 05, 2025 (GLOBE NEWSWIRE) -- Nuclear Medicine Market Size & Growth Analysis: According to SNS Insider, The Global Nuclear Medicine Market size was valued at USD 11.1 billion in 2023...
September 03, 2024 09:00 ET | Source: CenExel Clinical Research

CenExel iResearch and CenExel ACMR Unveil Dedicated PET Scan Unit for Specialized Research

Atlanta, GA, Sept. 03, 2024 (GLOBE NEWSWIRE) -- CenExel iResearch and CenExel ACMR, two premier Centers of Excellence located in Atlanta, Georgia, are thrilled to announce the launch of a dedicated...
June 17, 2024 08:51 ET | Source: Curium

Curium Continues to Make Strong Progress in European Roll-Out Of PYLCLARI® – 18F-PSMA PET Diagnostics of Patients With Prostate Cancer

First doses of PYLCLARI® administered in Austria in early May 2024PYLCLARI® now available in France, Germany, Greece, Italy, and the Netherlands PARIS, June 17, 2024 (GLOBE NEWSWIRE) -- Curium, a...
June 17, 2024 08:51 ET | Source: Curium

Curium gibt erste kommerzielle Dosen von PYLCLARI® - 18F-PSMA PET radiopharmazeutikum in Österreich bekannt

Erste Dosen von PYLCLARI® werden Anfang Mai 2024 in Österreich verabreichtPYLCLARI® jetzt auch in Frankreich, Deutschland, Griechenland, Italien und den Niederlanden erhältlich PARIS, June 17, 2024 ...
October 11, 2023 08:43 ET | Source: Research and Markets

UK's First National Total-Body PET Imaging Platform Boosts Demand for Expert PET Market Insights

Dublin, Oct. 11, 2023 (GLOBE NEWSWIRE) -- As the UK takes a monumental leap towards advanced medical imaging with the unveiling of the National PET Imaging Platform (NPIP), industry professionals,...
May 26, 2023 03:42 ET | Source: Curium

Curium Receives Positive CHMP Opinion of PYLCLARI® for Primary Staging of Patients With High-Risk PCa Prior to Initial Curative Therapy and to Localize Recurrence of PCa in Patients With a Suspected Recurrence Based on Increasing Serum Prostate-Specific Antigen (PSA) Levels After Primary Treatment With Curative Intent

If approved for Europe, PYLCLARI® (INN: Piflufolastat (18F) formerly known as [18F]-DCFPyL) will offer prostate cancer patients access to a diagnostic imaging agent more sensitive than conventional...